Comparison of absolute and relative errors. by Lahoucine Tadoummant (21647670)

Subjects:

Rate of convergence for relative errors. by Lahoucine Tadoummant (21647670)

Subjects:

(a) Absolute error of the example 3, Y(x,y) for scale level ranging from 2 to 7. by Lahoucine Tadoummant (21647670)

Subjects:

(a) Comparison of the approximate solution with the exact solution for the example 1. by Lahoucine Tadoummant (21647670)

Subjects:

Approximate Y(x,y) for different value of and for test problem 3. by Lahoucine Tadoummant (21647670)

Subjects:

(a) Comparison of the approximate solution with the exact solution for the example 2. by Lahoucine Tadoummant (21647670)

Subjects:

(a) Comparison of the approximate solution X(x,y) with the exact solution of the problem 3. by Lahoucine Tadoummant (21647670)

Subjects:

Approximate X(x,y) for different value of and for test problem 3. by Lahoucine Tadoummant (21647670)

Subjects:

(a) Absolute error of the example 3, X(x,y) for scale level ranging from 2 to 7. by Lahoucine Tadoummant (21647670)

Subjects:

Demographic information of participants. by Zixia Bu (21475019)

“…The positive correlation between HSK and PA did not change significantly (r = 0.15, r = 0.18, P < 0.01). The positive correlation of PA itself decreased over time (r = 0.83, r = 0.76, P < 0.01). …”

Advantages of Novel Anti-cancer Selenosemicarbazones: Preferential Reactivity of Their Fe(III), Cu(II), and Zn(II) Complexes with Key Physiological Reductants/Ligands Versus Isoste... by Mahendiran Dharmasivam (14165426)

“…This was ascribed to the decreased potentials of their Fe(III) complexes and steric hindrance effects. …”

Advantages of Novel Anti-cancer Selenosemicarbazones: Preferential Reactivity of Their Fe(III), Cu(II), and Zn(II) Complexes with Key Physiological Reductants/Ligands Versus Isoste... by Mahendiran Dharmasivam (14165426)

“…This was ascribed to the decreased potentials of their Fe(III) complexes and steric hindrance effects. …”

Excluded skewed studies. by Solima Sabeel (9545738)

Subjects:

Stratified meta-analysis for treatment duration effects of statins versus placebo subdivided into 3-4 months and longer than 4 months of treatment for by Solima Sabeel (9545738)

Subjects:

Reason for exclusion of all 6514 screened articles. by Solima Sabeel (9545738)

Subjects:

Methodological items for non-randomized studies (MINORS). by Solima Sabeel (9545738)

Subjects:

Jadad Score of randomized controlled trials. by Solima Sabeel (9545738)

Subjects:

Summary of randomized controlled trials. by Solima Sabeel (9545738)

Subjects:

LDL-C meta-analysis showing in (A) the overall effects of different statin types versus placebo and (B) stratified by statin treatment duration for 3-4 months and longer than 4 mon... by Solima Sabeel (9545738)

Subjects:

Overall analysis of randomized controlled trials. by Solima Sabeel (9545738)

Subjects: